CoChat

OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency

Open access
Ullrich, M, Weber, M, Post, A M, Popp, S, Grein, J, Zechner, M, Guerrero González, H, Kreis, A, Schmitt, A G, Üçeyler, N, Lesch, K-P, Schuh, K · 2018 · Molecular Psychiatry
Cited by 87

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disease affecting about 2% of the general population. It is characterized by persistent intrusive thoughts and repetitive ritualized behaviors. While gene variations, malfunction of cortico-striato-thalamo-cortical (CSTC) circuits, and dysregulated synaptic transmission have been implicated in the pathogenesis of OCD, the underlying mechanisms remain largely unknown. Here we show that OCD-like behavior in mice is caused by deficiency of SPRED2, a protein expressed in various brain regions and a potent inhibitor of Ras/ERK-MAPK signaling. Excessive self-grooming, reflecting OCD-like behavior in rodents, resulted in facial skin lesions in SPRED2 knockout (KO) mice. This was alleviated by treatment with the selective serotonin reuptake inhibitor fluoxetine. In addition to the previously suggested involvement of cortico-striatal circuits, electrophysiological measurements revealed altered transmission at thalamo-amygdala synapses and morphological differences in lateral amygdala neurons of SPRED2 KO mice. Changes in synaptic function were accompanied by dysregulated expression of various pre- and postsynaptic proteins in the amygdala. This was a result of altered gene transcription and triggered upstream by upregulated tropomyosin receptor kinase B (TrkB)/ERK-MAPK signaling in the amygdala of SPRED2 KO mice. Pathway overactivation was mediated by increased activity of TrkB, Ras, and ERK as a specific result of SPRED2 deficiency and not elicited by elevated brain-derived neurotrophic factor levels. Using the MEK inhibitor selumetinib, we suppressed TrkB/ERK-MAPK pathway activity in vivo and reduced OCD-like grooming in SPRED2 KO mice. Altogether, this study identifies SPRED2 as a promising new regulator, TrkB/ERK-MAPK signaling as a novel mediating mechanism, and thalamo-amygdala synapses as critical circuitry involved in the pathogenesis of OCD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2016.232

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 49

  1. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M . Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003; 73: 370–376. · DOI · Paper page
  2. Hemmings SM, Kinnear CJ, Van der Merwe L, Lochner C, Corfield VA, Moolman-Smook JC et al. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD). World J Biol Psychiatry 2008; 9: 126–134. · DOI · Paper page
  3. Oliveira-Maia AJ, Castro-Rodrigues P . Brain-derived neurotrophic factor: a biomarker for obsessive-compulsive disorder? Front Neurosci 2015; 9: 134. · DOI
  4. Alonso P, Gratacos M, Menchon JM, Saiz-Ruiz J, Segalas C, Baca-Garcia E et al. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder. Biol Psychiatry 2008; 63: 619–628. · DOI
  5. Olsen D, Kaas M, Schwartz O, Nykjaer A, Glerup S . Loss of BDNF or its receptors in three mouse models has unpredictable consequences for anxiety and fear acquisition. Learn Mem 2013; 20: 499–504. · DOI
  6. Guiton M, Gunn-Moore FJ, Stitt TN, Yancopoulos GD, Tavare JM . Identification of in vivo brain-derived neurotrophic factor-stimulated autophosphorylation sites on the TrkB receptor tyrosine kinase by site-directed mutagenesis. J Biol Chem 1994; 269: 30370–30377. · DOI
  7. Wakioka T, Sasaki A, Kato R, Shouda T, Matsumoto A, Miyoshi K et al. Spred is a Sprouty-related suppressor of Ras signalling. Nature 2001; 412: 647–651. · DOI · Paper page
  8. King JA, Straffon AF, D'Abaco GM, Poon CL, I ST, Smith CM et al. Distinct requirements for the Sprouty domain for functional activity of Spred proteins. Biochem J 2005; 388 (Pt 2): 445–454. · DOI
  9. Bundschu K, Walter U, Schuh K . Getting a first clue about SPRED functions. Bioessays 2007; 29: 897–907. · DOI · Paper page
  10. Bundschu K, Gattenlohner S, Knobeloch KP, Walter U, Schuh K . Tissue-specific Spred-2 promoter activity characterized by a gene trap approach. Gene Expr Patterns 2006; 6: 247–255. · DOI
  11. Engelhardt CM, Bundschu K, Messerschmitt M, Renne T, Walter U, Reinhard M et al. Expression and subcellular localization of Spred proteins in mouse and human tissues. Histochem Cell Biol 2004; 122: 527–538. · DOI
  12. Phoenix TN, Temple S . Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. Genes Dev 2010; 24: 45–56. · DOI · Paper page
  13. Mardakheh FK, Yekezare M, Machesky LM, Heath JK . Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling. J Cell Biol 2009; 187: 265–277. · DOI
  14. Brems H, Chmara M, Sahbatou M, Denayer E, Taniguchi K, Kato R et al. Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 2007; 39: 1120–1126. · DOI · Paper page
  15. Denayer E, Ahmed T, Brems H, Van Woerden G, Borgesius NZ, Callaerts-Vegh Z et al. Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J Neurosci 2008; 28: 14443–14449. · DOI · Paper page
  16. Inoue H, Kato R, Fukuyama S, Nonami A, Taniguchi K, Matsumoto K et al. Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness. J Exp Med 2005; 201: 73–82. · DOI
  17. Ullrich M, Bundschu K, Benz PM, Abesser M, Freudinger R, Fischer T et al. Identification of SPRED2 (Sprouty-related Protein with EVH1 Domain 2) as a Negative Regulator of the Hypothalamic-Pituitary-Adrenal Axis. J Biol Chem 2011; 286: 9477–9488. · DOI
  18. Bundschu K, Knobeloch KP, Ullrich M, Schinke T, Amling M, Engelhardt CM et al. Gene disruption of Spred-2 causes dwarfism. J Biol Chem 2005; 280: 28572–28580. · DOI
  19. Ullrich M, Schuh K . Gene trap: knockout on the fast lane. Methods Mol Biol (Clifton, NJ) 2009; 561: 145–159. · DOI
  20. Post AM, Weyers P, Holzer P, Painsipp E, Pauli P, Wultsch T et al. Gene-environment interaction influences anxiety-like behavior in ethologically based mouse models. Behav Brain Res 2011; 218: 99–105. · DOI
  21. Bourin M, Hascoet M . The mouse light/dark box test. Eur J Pharmacol 2003; 463: 55–65. · DOI · Paper page
  22. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL . Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55–63. · DOI · Paper page
  23. Hargreaves K, Dubner R, Brown F, Flores C, Joris J . A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77–88. · DOI · Paper page
  24. Paxinos G, Franklin KBJ . The Mouse Brain in Stereotaxic Coordinates. Academic Press, 1997.
  25. Nietzer SL, Bonn M, Jansen F, Heiming RS, Lewejohann L, Sachser N et al. Serotonin transporter knockout and repeated social defeat stress: impact on neuronal morphology and plasticity in limbic brain areas. Behav Brain Res 2011; 220: 42–54. · DOI
  26. Chen Y, Boettger MK, Reif A, Schmitt A, Uceyler N, Sommer C . Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain 2010; 6: 13.
  27. Huang GJ, Bannerman D, Flint J . Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice. Mol Psychiatry 2008; 13: 119–121. · DOI
  28. Bartz JA, Hollander E . Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 338–352. · DOI · Paper page
  29. Association AP (ed). Diagnostic and statistical manual of mental disorders. 5th Edition. American Psychiatric Publishing: Arlington, VA, 2013.
  30. Findley DB, Leckman JF, Katsovich L, Lin H, Zhang H, Grantz H et al. Development of the Yale Children's Global Stress Index (YCGSI) and its application in children and adolescents ith Tourette's syndrome and obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2003; 42: 450–457. · DOI
  31. Toro J, Cervera M, Osejo E, Salamero M . Obsessive-compulsive disorder in childhood and adolescence: a clinical study. J Child Psychol Psychiatry 1992; 33: 1025–1037. · DOI · Paper page
  32. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 9–20. · DOI · Paper page
  33. Kluge M, Schussler P, Kunzel HE, Dresler M, Yassouridis A, Steiger A . Increased nocturnal secretion of ACTH and cortisol in obsessive compulsive disorder. J Psychiatr Res 2007; 41: 928–933. · DOI
  34. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 595–606. · DOI · Paper page
  35. Albelda N, Joel D . Current animal models of obsessive compulsive disorder: an update. Neuroscience 2012; 211: 83–106. · DOI
  36. Davydova D, Marini C, King C, Klueva J, Bischof F, Romorini S et al. Bassoon specifically controls presynaptic P/Q-type Ca(2+) channels via RIM-binding protein. Neuron 2014; 82: 181–194. · DOI · Paper page
  37. Benarroch EE . Metabotropic glutamate receptors: synaptic modulators and therapeutic targets for neurologic disease. Neurology 2008; 70: 964–968. · DOI · Paper page
  38. Niswender CM, Conn PJ . Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 2010; 50: 295–322. · DOI · Paper page
  39. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P et al. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 1999; 23: 583–592. · DOI · Paper page
  40. Keith D, El-Husseini A . Excitation control: balancing PSD-95 function at the synapse. Front Mol Neurosci 2008; 1: 4. · DOI · Paper page
  41. Vanderklish PW, Edelman GM . Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons. Proc Natl Acad Sci USA 2002; 99: 1639–1644. · DOI · Paper page
  42. Chakravarthy S, Saiepour MH, Bence M, Perry S, Hartman R, Couey JJ et al. Postsynaptic TrkB signaling has distinct roles in spine maintenance in adult visual cortex and hippocampus. Proc Natl Acad Sci USA 2006; 103: 1071–1076. · DOI · Paper page
  43. Meng S, Zhang M, Pan W, Li Z, Anderson DH, Zhang S et al. Tyrosines 303/343/353 within the Sprouty-related domain of Spred2 are essential for its interaction with p85 and inhibitory effect on Ras/ERK activation. Int J Biochem Cell Biol 2012; 44: 748–758. · doi:10.1016/j.biocel.2012.01.014
  44. Quintanar-Audelo M, Yusoff P, Sinniah S, Chandramouli S, Guy GR . Sprouty-related Ena/VASP homology 1-domain-containing protein (SPRED) 1, a SHP2 substrate in the Ras/ERK pathway. J Biol Chem 2011; 286: 23102–23112. · DOI
  45. Kelleher RJ 3rd, Govindarajan A, Jung HY, Kang H, Tonegawa S . Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 2004; 116: 467–479. · DOI · Paper page
  46. Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH et al. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008; 135: 549–560. · DOI · Paper page
  47. Giese KP, Mizuno K . The roles of protein kinases in learning and memory. Learn Mem 2013; 20: 540–552. · DOI · Paper page
  48. Bartholomeusz C, Xie X, Pitner MK, Kondo K, Dadbin A, Lee J et al. MEK inhibitor selumetinib (AZD6244; ARRY-142886) prevents lung metastasis in a triple-negative breast cancer xenograft model. Mol Cancer Ther 2015; 14: 2773–2781. · DOI
  49. Carvajal RD, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Kudchadkar RR et al. Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. J Am Med Assoc 2014; 311: 2397–2405. · DOI · Paper page

Cited by

See all 87

Metadata

Authors
Ullrich, M., Weber, M., Post, A. M., Popp, S., Grein, J., Zechner, M., Guerrero González, H., Kreis, A., Schmitt, A. G., Üçeyler, N., Lesch, K.-P., & Schuh, K.
Venue
Molecular Psychiatry
Published
2017-01-10
Volume
23
Issue
2
Pages
444-458
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2568767106
Cited by
87
References
29
FWCI
7.59
Type
journal article
Language
en
Open access
hybrid
Licence
creativecommons.org/licenses/by-nc-nd/4.0 (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency. https://app.cochat.ai/papers/10.1038/mp.2016.232
The paper
Ullrich, M., Weber, M., Post, A. M., Popp, S., Grein, J., Zechner, M., Guerrero González, H., Kreis, A., Schmitt, A. G., Üçeyler, N., Lesch, K.-P., & Schuh, K. (2018). OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency. Molecular Psychiatry. https://doi.org/10.1038/mp.2016.232

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.